Banking human pluripotent stem cell lines for clinical application?

Journal of Dental Research

Volumn 89, Issue 8, 2010, Pages 757-758

  Nakatsuji, N ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

BIOLOGICAL THERAPY; CELL LINE; CYTOLOGY; HEALTH CARE FACILITY; HUMAN; IMMUNOLOGY; NOTE; PLURIPOTENT STEM CELL; TOOTH PULP;

BIOLOGICAL SPECIMEN BANKS; CELL LINE; DENTAL PULP; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; TISSUE THERAPY;

EID: 77955476626     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510375288     Document Type: Editorial

References (13)

1. Chin MH, Mason MJ, Xie W., Volinia S., Singer M., Peterson C., et al. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5: 111-123.
2. Doi A., Park IH, Wen B., Murakami P., Aryee MJ, Irizarry R., et al. (2009). Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41: 1350-1353.
3. Feng Q., Lu S., Klimanskaya I., Gomes I., Kim D., Chung Y. (2010). Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28: 704-712.
4. Kanatsu-Shinohara M., Inoue K., Lee J., Yoshimoto M., Ogonuki N., Miki H., et al. (2004). Generation of pluripotent stem cells from neonatal mouse testis. Cell 119: 1001-1012.
5. Kim K., Lerou P., Yabuuchi A., Lengerke C., Ng K., West J., et al. (2007). Histocompatible embryonic stem cells by parthenogenesis. Science 315: 482-486.
6. Lin G., Xie Y., Poyang Q., Qian X., Xie P., Zhou X., et al. (2009). HLAmatching potential of an established human embryonic stem cell bank in China. Cell Stem Cell 5: 461-465.
7. Nakajima F., Tokunaga K., Takatsuki N. (2007). Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. Stem Cells 25: 983-985.
8. Nakatsuji N., Nakajima F., Tokunaga K. (2008). HLA-haplotype banking and iPS cells. Nat Biotechnol 26: 739-740.
9. Pick M., Stelzer Y., Bar-Nur O., Mayshar Y., Eden A., Benvenisty N. (2009). Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 27: 2686-2690.
10. Stadtfeld M., Apostolou E., Akutsu H., Fukuda A., Follett P., Natesan S., et al. (2010). Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465: 175-181.
11. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
12. Tamaoki N., Takahashi K., Tanaka T., Ichisaka T., Aoki H., Takeda-Kawaguchi T., et al. (2010). Dental pulp cells for induced pluripotent stem cell banking. J Dent Res 89: 773-778.
13. Taylor CJ, Bolton EM, Pocock S., Sharples LD, Pedersen RA, Bradley JA (2005). Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366: 2019-2025.